Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CASTAIGNE S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Terre, C; Bastie, JN; Garcia, I; Suzan, F; Cayuela, JM; Therond, P; Castaigne, S
      BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridizationin an acute leukemia with two BCR/ABL positive clones, one Ph-negative andone Ph-positive

      CANCER GENETICS AND CYTOGENETICS
    2. Suzan, F; Terre, C; Garcia, I; Bastie, JN; Baumelou, E; Gluckman, E; Castaigne, S
      Three cases of typical aplastic anaemia associated with a Philadelphia chromosome

      BRITISH JOURNAL OF HAEMATOLOGY
    3. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    4. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
      Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

      LEUKEMIA
    5. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
      Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Bastie, JN; Cazals-Hatem, D; Daniel, MT; D'Agay, MF; Rabian, CL; Glaisner, S; Noel-Walter, MP; Dabout, D; Flandrin, G; Dombret, H; Poisson, D; Degos, L; Castaigne, S
      Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment

      LEUKEMIA & LYMPHOMA
    7. Bouabdallah, R; Lefrere, F; Rose, C; Chaibi, P; Harousseau, JL; Vernant, JP; Castaigne, S; Bauduer, F; Zini, JM; Coso, D; Varet, B; Robert, J; Fenaux, P
      A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

      LEUKEMIA
    8. Terre, C; Garcia, I; Bastie, JN; Mayeur, D; Decombe, L; Gruyer, P; Berger, R; Castaigne, S
      A case of chronic neutrophilic leukemia with deletion (11)(q23)

      CANCER GENETICS AND CYTOGENETICS
    9. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    10. MALOISEL F; BENBOUBKER L; CARCEL C; LEDERLIN P; SEDILLOT M; RAPP MJ; GARDEMBAS M; GANHDOUR C; BLANC M; CHRISTIAN B; CASTAIGNE S; CHERON N; CHAUVENET L; DREYFUSS B; SALLES B; MOREAU P; PEGOURIE B; OBERLING F
      HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY

      British Journal of Haematology
    11. CASTAIGNE S; ARCHIMBAUD A; BORDESSOULE D; TILLY H; DOMBRET H; DEREVEL T; SIMON M; RENOUX M; JANVIER M; GROSBOIS M; DUPRIEZ B; ZINI JM; TERTIAN G; BAY O; FENAUX P; DEGOS L; CHASTANG C
      INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL

      British Journal of Haematology
    12. TAKSIN AL; THOMAS X; CASTAIGNE S; ROUSSELOT P; DEGOS L; ARCHIMBAUD E; DOMBRET H
      LIMITS FOR INTENSIFYING INDUCTION THERAPY IN YOUNGER PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)

      British Journal of Haematology
    13. CHALIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; TAKSIN AL; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
      MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS OR MORE

      British Journal of Haematology
    14. KELL WJ; HOFMANN WK; HOELZER D; CHOMIENNE C; GANSER A; FENAUX P; CASTAIGNE S; BURNETT R; BURNETT AK
      9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA

      British Journal of Haematology
    15. CHAIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
      MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS AND OVER - A SINGLE INSTITUTION EXPERIENCE

      Blood
    16. FENAUX P; CHASTANG C; SANZ M; THOMAS X; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTOUN R; GARDIN C; MALOISEL F; FEY M; TRAVADE P; REIFFERS J; STAMATOULAS A; STOPPA AM; CAILLOT D; LEFRERE F; HAYAT M; CASTAIGNE S; CHOMIENNE C; DEGOS L
      ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL

      Blood
    17. FENAUX P; CHASTANG C; CASTAIGNE S; ARCHIMBAUD E; LINK H; FEY M; GUERCI A; FEGUEUX N; BOWEN D; LOWENBERG B; GARDIN C; MALOISEL F; STAMATOULAS A; STOPPA AM; SADOUN A; JACKY E; GANSER A; AUZANNEAU G; CHOMIENNE C; DEGOS L
      LONG-TERM FOLLOW-UP CONFIRMS THE SUPERIORITY OF ATRA COMBINED WITH CHEMOTHERAPY (CT) OVER CT ALONE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - (APL-91 TRIAL)

      Blood
    18. COUMAU E; PEYNET J; HARZIC M; BEAL G; CASTAIGNE S; LEVERGER G; FOUCAUD P
      SEVERE PARVOVIRUS B19 INFECTION IN AN IMM UNOCOMPETENT HEMOPHILIAC-A CHILD

      Archives de pediatrie
    19. CORNIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
      ACQUIRED-RESISTANCE TO ALL-TRANS-RETINOIC ACID THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA

      Onkologie
    20. GODEAU B; BIERLING P; OKSENHENDLER E; CASTAIGNE S; DECONINCK E; WECHSLER B
      HIGH-DOSE DEXAMETHASONE THERAPY FOR RESISTANT AUTOIMMUNE THROMBOCYTOPENIC PURPURA

      American journal of hematology
    21. FENAUX P; CHASTANG C; SANZ M; ARCHIMBAUD E; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTTOUN R; GARDIN C; MALOSIEL F; FEY M; CASTAIGNE S; CHOMIENNE C; DEGOS L
      EFFECT OF ATRA IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - VALIDATION OF SHORT-TERM EFFECT IN A LARGE MULTICENTER TRIAL (APL-93TRIAL) AND ASSESSMENT OF LONG-TERM BENEFIT (APL-91 TRIAL)

      Blood
    22. CASTAIGNE S; ARCHIMBAUD E; BORDESSOULE D; FENAUX P; TILLY H; DEREVEL T; SIMON M; JANVIER M; RENOUX M; GROSBOIS B; DUPRIEZ B; ZINI JM; TERTIAN G; LEGROS M; CHASTANG C; DEGOS L
      SEQUENTIAL INDUCTION OR DOUBLE INDUCTION CHEMOTHERAPY INCREASE DISEASE-FREE SURVIVAL COMPARED TO 3-CHEMOTHERAPY IN LESS-THAN 50 YEARS ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML)(7)

      Blood
    23. BASTIE JN; DANIEL MT; CAZALSHATEM D; NIEZ P; DABOUT D; GLAISNER S; DAGAY MF; FLANDRIN G; DEGOS L; CASTAIGNE S
      LONG-TERM FOLLOW-UP AFTER 2-CHLORODEOXYADENOSINE (2CDA) TREATMENT IN 30 PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL)

      Blood
    24. MEUNIER P; CASTAIGNE S; BASTIE JN; CHOSIDOW O; ARACTINGI S
      CUTANEOUS REACTIONS AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE

      Acta dermato-venereologica
    25. FENAUX P; CHASTANG C; CHOMIENNE C; CASTAIGNE S; SANZ M; LINK H; LOWENBERG B; FEY M; ARCHIMBAUD E; DEGOS L
      TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) BY ALL TRANSRETINOIC ACID (ATRA) COMBINED WITH CHEMOTHERAPY - THE EUROPEAN EXPERIENCE

      Leukemia & lymphoma
    26. DOMBRET H; GEIGER S; DANIEL MT; GLAISNER S; MICLEA JM; CASTAIGNE S; MERLEBERAL H; LACOMBE C; CHOMIENNE C; DEGOS L
      CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS

      Leukemia
    27. DOMBRET H; SCROBOHACI ML; DANIEL MT; MICLEA JM; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
      IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Leukemia
    28. SCROBOHACI ML; DOMBRET H; DANIEL MT; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
      IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Thrombosis and haemostasis
    29. AZAGURY M; DOMBRET H; CASTAIGNE S; DEGOS L
      GROWTH-HORMONE AND ACUTE PROMYELOCYTIC LEUKEMIA

      Medical and pediatric oncology
    30. JOURDAN E; DOMBRET H; GLAISNER S; MICLEA JM; CASTAIGNE S; DEGOS L
      UNEXPECTED HIGH-INCIDENCE OF INTRACRANIAL SUBDURAL-HEMATOMA DURING INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA WITH A MONOBLASTIC COMPONENT

      British Journal of Haematology
    31. DEGOS L; DOMBRET H; CHOMIENNE C; DANIEL MT; MICLEA JM; CHASTANG C; CASTAIGNE S; FENAUX P
      ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATING AGENT IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    32. ROUSSELOT P; HARDAS B; PATEL A; GUIDEZ F; GAKEN J; CASTAIGNE S; DEJEAN A; DETHE H; DEGOS L; FARZANEH F; CHOMIENNE C
      THE PML-RAR-ALPHA GENE-PRODUCT OF THE T(1517) TRANSLOCATION INHIBITS RETINOIC ACID-INDUCED GRANULOCYTIC DIFFERENTIATION AND MEDIATED TRANSACTIVATION IN HUMAN MYELOID CELLS

      Oncogene
    33. COMIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
      IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    34. BALITRAND N; SCHLAGETER MHL; DEGENTILE A; TOUBERT ME; KRAWICE I; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L; CHOMIENNE C
      MODULATION OF IL-8, IL-1-BETA, AND G-CSF SECRETION BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    35. DEGENTILE A; TOUBERT ME; DUBOIS C; KRAWICE I; SCHLAGETER MH; BALITRAND N; CASTAIGNE S; DEGOS L; RAIN JD; NAJEAN Y; CHOMIENNE C
      INDUCTION OF HIGH-AFFINITY GM-CSF RECEPTORS DURING ALL-TRANS-RETINOICACID TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    36. DOMBRET H; CASTAIGNE S; FENAUX P; CHOMIENNE C; DEGOS L
      INDUCTION TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA USING ALL-TRANS-RETINOIC ACID - CONTROVERSIES ABOUT DOSAGE, ADVANTAGES AND SIDE-EFFECT MANAGEMENT

      Leukemia
    37. CORNIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
      IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    38. BRICE P; PAUTIER P; MAROLLEAU JP; CASTAIGNE S; GISSELBRECHT C
      PREGNANCY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS

      Nouvelle revue francaise d'hematologie
    39. CASTAIGNE S; ARCHIMBAUD E; FENAUX P; BORDESSOULE D; TILLY H; SIMON M; DUPRIEZ B; AUZANNEAU G; LEGROS M; TERTIAN G; JANVIER M; RENOUX M; SCHOENWALD M
      ROLE OF DOUBLE INDUCTION IN THE TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS - INTERIM RESULTS OF THE LAM90 PROTOCOL

      Nouvelle revue francaise d'hematologie
    40. FENAUX P; WATTEL E; ARCHIMBAUD E; SANZ M; HECQUET B; FEGUEUX N; GUERCI A; LINK H; FEY M; CASTAIGNE S; DEGOS L
      PROLONGED FOLLOW-UP CONFIRMS THAT ALL-TRANS-RETINOIC ACID FOLLOWED BYCHEMOTHERAPY REDUCES THE RISK OF RELAPSE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    41. FENAUX P; CHASTANG C; CASTAIGNE S; ARCHIMBAUD E; SANZ M; LINK H; GUERCI A; FEGUEUX N; ZITTOUN R; STOPPA AM; TRAYADE P; LAMY T; MALOISEL F; SADOUN A; SANMIGUEL J; VEIL A; RAYON C; CONDE E; FEY M; BORDESSOULE D; GANSER A; BOWEN D; DREYFUS F; HUGUET F; TILLY H; GUY H; AUZANNEAU G; CHOMIENNE C; DEGOS L
      TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL TRANSRETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CHEMOTHERAPY (CT) - UPDATED RESULTS OF THE EUROPEAN GROUP

      Blood
    42. DUBOIS C; SCHLAGETER MH; DEGENTILE A; GUIDEZ F; BALITRAND N; TOUBERT ME; KRAWICE I; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L; CHOMIENNE C
      HEMATOPOIETIC GROWTH-FACTOR EXPRESSION AND ATRA SENSITIVITY IN ACUTE PROMYELOCYTIC BLAST CELLS

      Blood
    43. FERME C; LEPAGE E; BRICE P; DAGAY MF; FERMAND JP; CASTAIGNE S; FRIJA J; MIOT C; MARTY M; GISSELBRECHT C
      COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS

      International journal of radiation oncology, biology, physics
    44. WANG ZY; CASTAIGNE S; BERNARD J; BESSIS B; CHOMIENNE C; BEUTLER E; CRONKITE EP; DETHE G; BINET JL; SACHS L; BULL B; DIGHIERO G; DETHE H
      PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) - DISCUSSION

      Blood cells
    45. DELVA L; CORNIC M; BALITRAND N; GUIDEZ F; MICLEA JM; DELMER A; TEILLET F; FENAUX P; CASTAIGNE S; DEGOS L; CHOMIENNE C
      RESISTANCE TO ALL-TRANS-RETINOIC ACID (ATRA) THERAPY IN RELAPSING ACUTE PROMYELOCYTIC LEUKEMIA - STUDY OF IN-VITRO ATRA SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN-LEVELS IN LEUKEMIC-CELLS

      Blood
    46. CASTAIGNE S; LEFEBVRE P; CHOMIENNE C; SUC E; RIGALHUGUET F; GARDIN C; DELMER A; ARCHIMBAUD E; TILLY H; JANVIER M; ISNARD F; TRAVADE P; MONTFORT L; DELANNOY A; RAPP MJ; CHRISTIAN B; MONTASTRUC M; WEH H; FENAUX P; DOMBRET H; GOURMEL B; DEGOS L
      EFFECTIVENESS AND PHARMACOKINETICS OF LOW-DOSE ALL-TRANS-RETINOIC ACID (25 MG M2) IN ACUTE PROMYELOCYTIC LEUKEMIA/

      Blood
    47. FENAUX P; LEDELEY MC; CASTAIGNE S; ARCHIMBAUD E; CHOMIENNE C; LINK H; GUERCI A; DUARTE M; DANIEL MT; BOWEN D; HUEBNER G; BAUTERS F; FEGUEUX N; FEY M; SANZ M; LOWENBERG B; MALOISEL F; AUZANNEAU G; SADOUN A; GARDIN C; BASTION Y; GANSER A; JACKY E; DOMBRET H; CHASTANG C; DEGOS L
      EFFECT OF ALL TRANSRETINOIC ACID IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF A MULTICENTER RANDOMIZED TRIAL

      Blood
    48. DOMBRET H; RENESTO P; SCROBOHACI ML; GUERCI AP; BARUCHEL A; MOLINA L; RAPP MJ; CORDONNIER C; CASTAIGNE S; DEGOS L
      PLASMA-FREE SERINE-PROTEASE ACTIVITY (SPA) IN PATIENTS WITH ACUTE PRMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Blood
    49. DUBOIS C; SCHLAGETHER MH; GUIDEZ F; BALITRAND N; DEGENTILLE A; TOUBERT ME; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L
      CYTOKINE SECRETION STUDIES IN APL CELLS - MEANS TO EVALUATE ATRA INDUCED-DIFFERENTIATION AND PROLIFERATION

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 08:58:28